Table 3. Correlations among oxidative stress markers, cytokines, and Lp-PLA2 activity in the circulation and in PBMCs according to menopausal status.
Premenopausal women (n = 96) | Postmenopausal women (n = 80) | |||||||||||
Plasmaox-LDL | Plasma Lp-PLA2 activity | Nonstimulated PBMC Lp-PLA2 | Plasma ox-LDL | Plasma Lp-PLA2 activity | Nonstimulated PBMC Lp-PLA2 | |||||||
r0 | r1 | r0 | r1 | r0 | r1 | r0 | r1 | r0 | r1 | r0 | r1 | |
Plasma ox- LDL(U/L)∮ | - | - | 0.244* | 0.247* | 0.022 | 0.006 | - | - | 0.390*** | 0.394** | 0.215 | 0.154 |
Serum IL-6 (pg/mL)∮ | 0.042 | 0.051 | −0.150 | −0.154 | −0.020 | −0.032 | 0.171 | 0.143 | 0.022 | 0.016 | 0.019 | −0.017 |
Serum TNF-α (pg/mL)∮ | −0.037 | −0.016 | −0.178 | −0.202 | 0.101 | 0.068 | 0.090 | 0.031 | −0.022 | −0.018 | 0.030 | −0.008 |
Serum IL-1ß (pg/mL)∮ | −0.018 | −0.020 | 0.042 | 0.033 | 0.073 | 0.042 | −0.061 | −0.062 | −0.050 | −0.046 | −0.022 | −0.048 |
Lp-PLA2 activity (nmol/mL/min) | 0.244* | 0.247* | - | - | 0.427*** | 0.422*** | 0.390*** | 0.394** | - | - | 0.380** | 0.374** |
Nonstimulated PBMCs | ||||||||||||
IL-6 (pg/mL)∮ | 0.058 | 0.042 | 0.326** | 0.318** | 0.363*** | 0.353** | 0.230* | 0.222 | 0.051 | 0.073 | 0.127 | 0.121 |
TNF-α (pg/mL)∮ | 0.106 | 0.072 | 0.209* | 0.202 | 0.205* | 0.198 | 0.308** | 0.307** | 0.171 | 0.208 | 0.032 | 0.022 |
IL-1ß (pg/mL)∮ | 0.056 | 0.035 | 0.277** | 0.269** | 0.272** | 0.255* | 0.304** | 0.301** | 0.220 | 0.251* | 0.080 | 0.067 |
Lp-PLA2 activity (nmol/mL/min) | 0.022 | 0.006 | 0.427*** | 0.422*** | - | - | 0.215 | 0.154 | 0.380** | 0.374** | - | - |
Pearson and partial correlation analysis, r0: unadjusted, r1: adjusted for age, BMI, and alcohol consumption,
*P<0.05,
**P<0.01,
***P<0.001,
tested by log-transformed.